Approvals/NMPA/Henagliflozin Proline, Retagliptin Phosphate and Metformin Hydrochloride Sustained-release Tablets（Ⅰ）

Approved

化学药品

Henagliflozin Proline, Retagliptin Phosphate and Metformin Hydrochloride Sustained-release Tablets（Ⅰ）

山东盛迪医药有限公司🇨🇳 National Medical Products Administration

Approval Id: 8oHHGYnCYa6
Approval Number: 国药准字H20250063
Generic Name: 恒格列净瑞格列汀二甲双胍缓释片(Ⅰ)
Generic Name En: Henagliflozin Proline, Retagliptin Phosphate and Metformin Hydrochloride Sustained-release Tablets（Ⅰ）
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 脯氨酸恒格列净5mg（按C₂₂H₂₄ClFO₇计）、磷酸瑞格列汀50mg（按C₁₉H₁₈F₆N₄O₃）与盐酸二甲双胍750mg（按C₄H₁₁N₅·HCl计）
Reg Date: 2025-10-21
Company Name: 山东盛迪医药有限公司
Company Address: 山东省济南市高新区大正路1777号生物医药园中小企业产业化基地5号楼102
Production Company Name: 山东盛迪医药有限公司
Production Company Address: 山东省济南市高新区大正路1777号生物医药园中小企业产业化基地2号楼
Company Detail Path: /organization/shan-dong-sheng-di-yi-yao-you-xian-gong-si
Production Company Detail Path: /organization/shan-dong-sheng-di-yi-yao-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Oct 21, 2025

Approval ID

8oHHGYnCYa6

Type

化学药品